BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $110,943 | -13.8% | 2,100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $128,688 | +8.3% | 2,100 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $118,797 | -0.6% | 2,100 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $119,574 | +6.4% | 2,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $112,392 | -10.4% | 2,100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $125,391 | -4.2% | 2,100 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $130,893 | +2.9% | 2,100 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $127,260 | +3.6% | 2,100 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $122,829 | +25.3% | 2,100 | -6.9% | 0.00% | +100.0% |
| Q4 2017 | $98,000 | -56.1% | 2,256 | -49.9% | 0.00% | -50.0% |
| Q2 2017 | $223,000 | -9.7% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $247,000 | -1.6% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $251,000 | +21.8% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $206,000 | +14.4% | 4,500 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $180,000 | +36.4% | 4,500 | +19.0% | 0.00% | 0.0% |
| Q1 2016 | $132,000 | -19.0% | 3,782 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $163,000 | -1.2% | 3,782 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $165,000 | -15.4% | 3,782 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $195,000 | – | 3,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |